SPDR Series Trust - State Street SPDR S&P Biotech ETF
US ˙ ARCA ˙ US78464A8707

SecurityXBI / SPDR Series Trust - State Street SPDR S&P Biotech ETF
InstitutionCwm, Llc
Latest Disclosed Ownership28,608 shares
Latest Disclosed Value $ 3,654,114
Cwm, Llc ownership in XBI / SPDR Series Trust - State Street SPDR S&P Biotech ETF

On May 14, 2026 - Cwm, Llc filed a 13F-HR form disclosing ownership of 28,608 shares of SPDR Series Trust - State Street SPDR S&P Biotech ETF (US:XBI) valued at $3,654,100 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 24,492 shares of SPDR Series Trust - State Street SPDR S&P Biotech ETF. This represents a change in shares of 16.81% during the quarter. The current value of the position is $3,714,177 USD.

Cwm, Llc has a history of taking positions in derivatives of the underlying security (XBI) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

XBI / SPDR Series Trust - State Street SPDR S&P Biotech ETF Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F SPDR SERIES TRUST STATE STREET SPD 78464A870 28,608 4,116 16.81 3,654 182,600.00 0.0095
2026-01-26 2025-12-31 13F SPDR SERIES TRUST STATE STREET SPD 78464A870 24,492 10,699 77.57 3 100.00 0.0081
2025-10-15 2025-09-30 13F SPDR SERIES TRUST S&P BIOTECH 78464A870 13,793 614 4.66 1 0.00 0.0042
2025-07-25 2025-06-30 13F SPDR SERIES TRUST S&P BIOTECH 78464A870 13,179 -3,494 -20.96 1 0.00 0.0039
2025-05-01 2025-03-31 13F SPDR SER TR S&P BIOTECH 78464A870 16,673 3,616 27.69 1 0.00 0.0054
2025-02-04 2024-12-31 13F SPDR SER TR S&P BIOTECH 78464A870 13,057 2,818 27.52 1 0.00 0.0049
2024-10-08 2024-09-30 13F SPDR SER TR S&P BIOTECH 78464A870 10,239 1,849 22.04 1 0.0044
2024-07-10 2024-06-30 13F SPDR SER TR S&P BIOTECH 78464A870 8,390 866 11.51 1 0.0037
2024-04-05 2024-03-31 13F SPDR SER TR S&P BIOTECH 78464A870 7,524 -2,559 -25.38 1 0.0035
2024-02-01 2023-12-31 13F SPDR SER TR S&P BIOTECH 78464A870 10,083 -12,366 -55.08 1 -100.00 0.0048
2023-10-11 2023-09-30 13F SPDR SER TR S&P BIOTECH 78464A870 22,449 21,284 1,826.95 2 0.0100
2023-08-03 2023-06-30 13F SPDR SER TR S&P BIOTECH 78464A870 1,165 -48 -3.96 0 0.0006
2023-05-01 2023-03-31 13F SPDR SER TR S&P BIOTECH 78464A870 1,213 2 0.17 0 0.0006
2023-02-01 2022-12-31 13F SPDR SER TR S&P BIOTECH 78464A870 1,211 -2,392 -66.39 0 -100.00 0.0007
2022-10-27 2022-09-30 13F SPDR SER TR S&P BIOTECH 78464A870 3,603 816 29.28 286 38.16 0.0023
2022-07-28 2022-06-30 13F SPDR SER TR S&P BIOTECH 78464A870 2,787 -1,484 -34.75 207 -46.09 0.0016
2022-04-21 2022-03-31 13F SPDR SER TR S&P BIOTECH 78464A870 4,271 -425 -9.05 384 -27.00 0.0027
2022-01-31 2021-12-31 13F SPDR SER TR S&P BIOTECH 78464A870 4,696 288 6.53 526 -11.89 0.0037
2021-09-15 2021-06-30 13F/A-1 SPDR SER TR S&P BIOTECH 78464A870 4,408 0 0.00 597 0.00 0.0048
2021-07-29 2021-06-30 13F SPDR SER TR S&P BIOTECH 78464A870 4,408 0 597 0.0048
2021-09-15 2021-03-31 13F/A-1 SPDR SER TR S&P BIOTECH 78464A870 4,408 0 0.00 597 0.00 0.0048
2021-04-27 2021-03-31 13F SPDR SER TR S&P BIOTECH 78464A870 4,518 110 613 0.0054
2021-09-15 2020-12-31 13F/A-1 SPDR SER TR S&P BIOTECH 78464A870 4,408 0 0.00 597 0.00 0.0048
2021-01-27 2020-12-31 13F SPDR SER TR S&P BIOTECH 78464A870 4,848 440 682 0.0064
2021-09-15 2020-09-30 13F/A-1 SPDR SER TR S&P BIOTECH 78464A870 4,408 0 0.00 597 0.00 0.0048
2020-10-19 2020-09-30 13F SPDR SER TR S&P BIOTECH 78464A870 4,667 259 520 0.0058
2021-09-15 2020-06-30 13F/A-1 SPDR SER TR S&P BIOTECH 78464A870 4,408 0 0.00 597 0.00 0.0048
2020-07-22 2020-06-30 13F SPDR SER TR S&P BIOTECH 78464A870 35,274 30,866 3,949 0.0468
2021-09-15 2020-03-31 13F/A-1 SPDR SER TR S&P BIOTECH 78464A870 4,408 0 0.00 597 0.00 0.0048
2020-04-28 2020-03-31 13F SPDR SER TR S&P BIOTECH 78464A870 26,782 22,374 2,074 0.0309
2021-09-14 2019-12-31 13F/A-1 SPDR SER TR S&P BIOTECH 78464A870 4,408 0 0.00 597 0.00 0.0048
2020-01-27 2019-12-31 13F SPDR SERIES TRUST S&P BIOTECH 78464A870 24,128 19,720 2,295 0.0293
2021-09-14 2019-09-30 13F/A-1 SPDR SER TR S&P BIOTECH 78464A870 4,408 0 0.00 597 0.00 0.0048
2019-10-22 2019-09-30 13F SPDR SERIES TRUST S&P BIOTECH 78464A870 6,410 2,002 489 0.0071
2021-09-14 2019-06-30 13F/A-1 SPDR SER TR S&P BIOTECH 78464A870 4,408 0 0.00 597 0.00 0.0048
2019-07-31 2019-06-30 13F SPDR SERIES TRUST S&P BIOTECH 78464A870 6,644 2,236 583 0.0096
2021-09-02 2019-03-31 13F/A-1 SPDR SER TR S&P BIOTECH 78464A870 4,408 -4,428 -50.11 597 -5.84 0.0048
2019-04-22 2019-03-31 13F SPDR SERIES TRUST S&P BIOTECH 78464A870 11,034 2,198 999 0.0200
2019-01-25 2018-12-31 13F SPDR SERIES TRUST S&P BIOTECH 78464A870 8,836 8,575 3,285.44 634 2,436.00 0.0158
2018-10-29 2018-09-30 13F SPDR SERIES TRUST S&P BIOTECH 78464A870 261 261 25 0.0006
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-04-21 2022-03-31 13F SPDR SER TR S&P BIOTECH Call 0 -100.00 0 n/a n/a n/a
2022-01-31 2021-12-31 13F SPDR SER TR S&P BIOTECH Call 200 0.00 0 -100.00 n/a n/a n/a
2021-09-15 2021-06-30 13F/A SPDR SER TR S&P BIOTECH Call 200 0.00 1 0.00 n/a n/a n/a
2021-07-29 2021-06-30 13F SPDR SER TR S&P BIOTECH Call 200 1 n/a n/a n/a
2021-09-15 2021-03-31 13F/A SPDR SER TR S&P BIOTECH Call 200 0.00 1 0.00 n/a n/a n/a
2021-09-15 2020-12-31 13F/A SPDR SER TR S&P BIOTECH Call 200 0.00 1 0.00 n/a n/a n/a
2021-09-15 2020-09-30 13F/A SPDR SER TR S&P BIOTECH Call 200 0.00 1 0.00 n/a n/a n/a
2021-09-15 2020-06-30 13F/A SPDR SER TR S&P BIOTECH Call 200 0.00 1 0.00 n/a n/a n/a
2021-09-15 2020-03-31 13F/A SPDR SER TR S&P BIOTECH Call 200 0.00 1 0.00 n/a n/a n/a
2021-09-14 2019-12-31 13F/A SPDR SER TR S&P BIOTECH Call 200 0.00 1 0.00 n/a n/a n/a
2021-09-14 2019-09-30 13F/A SPDR SER TR S&P BIOTECH Call 200 0.00 1 0.00 n/a n/a n/a
2021-09-14 2019-06-30 13F/A SPDR SER TR S&P BIOTECH Call 200 0.00 1 0.00 n/a n/a n/a
2021-09-02 2019-03-31 13F/A SPDR SER TR S&P BIOTECH Call 200 1 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.